Basf Aktiengesellschaft

Nordmark-werke Gmbh

Wilhelm Kohlmann

Klaus Gutsche

Peter Scharwaechter

By Norma Kroemer, Legal Representative

By Maria Kroemer, Legal Representative

By Helmut Kroemer, Legal Representative

York Hartleben

Gerd Kroemer

Peter Scharwachter

Gerd Kroemer, Deceased

Wolfgang Heberle

Gerhard Kroemer, Deceased

The present invention is directed to new tertiary imidazolyl alcohols having the general formula (I) ##STR1## and to their pharmacologically acceptable acid addition salts with usual acids. The invention is further directed to a method for the treatment of generalized and local infections caused by fungi or yeasts by administering to a mammal suffering from such a disease a compound of the general formula (I) orally or externally in a suitable pharmaceutical preparation.

Tertiary imidazolyl alcohols and method for the treatment of generalized

5-Benzyl-4-amino-pyrimidine-2-amidines which may or may not be substituted in the phenyl ring, and their physiologically acceptable addition salts with acids, processes for their preparation, drugs containing these compounds, and their use in infectious diseases.

Novel amidino-benzylpyrimidines, processes for their manufacture and

Unsubstituted or substituted 5-phenyl- and 5-benzyl-4-amino-pyrimidine-2-imidoacid esters, their preparation, drugs containing these compounds, and their use in infectious diseases.

N-Pyrimidinyl-imidoacid esters and drugs containing the said compounds

5-Benzyl-2,4-diaminopyrimidines, in which the 2-amino group is substituted, and which may or may not be substituted in the phenyl ring, and their physiologically acceptable addition salts with acids, processes for their manufacture, drugs containing these compounds, and the use of the said compounds in infectious diseases.

Benzylpyrimidines, processes for their manufacture, and drugs containing

Growing community of inventors

Moorrege, Germany

Wilhelm Kohlmann